- Home
- DHC vs ARCT Comparison
DHC vs ARCT Comparison
Compare DHC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- ARCT
- Stock Information
- Founded
- DHC 1998
- ARCT 2013
- Country
- DHC United States
- ARCT United States
- Employees
- DHC N/A
- ARCT N/A
- Industry
- DHC Real Estate Investment Trusts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- DHC Real Estate
- ARCT Health Care
- Exchange
- DHC Nasdaq
- ARCT Nasdaq
- Market Cap
- DHC 856.4M
- ARCT 526.5M
- IPO Year
- DHC N/A
- ARCT N/A
- Fundamental
- Price
- DHC $4.14
- ARCT $21.57
- Analyst Decision
- DHC Buy
- ARCT Strong Buy
- Analyst Count
- DHC 2
- ARCT 9
- Target Price
- DHC $4.25
- ARCT $50.88
- AVG Volume (30 Days)
- DHC 794.4K
- ARCT 953.9K
- Earning Date
- DHC 11-03-2025
- ARCT 11-06-2025
- Dividend Yield
- DHC 0.96%
- ARCT N/A
- EPS Growth
- DHC N/A
- ARCT N/A
- EPS
- DHC N/A
- ARCT N/A
- Revenue
- DHC $1,522,835,000.00
- ARCT $122,122,000.00
- Revenue This Year
- DHC $4.05
- ARCT N/A
- Revenue Next Year
- DHC $3.08
- ARCT $28.92
- P/E Ratio
- DHC N/A
- ARCT N/A
- Revenue Growth
- DHC 4.29
- ARCT N/A
- 52 Week Low
- DHC $2.00
- ARCT $8.04
- 52 Week High
- DHC $4.65
- ARCT $23.60
- Technical
- Relative Strength Index (RSI)
- DHC 46.08
- ARCT 58.68
- Support Level
- DHC $3.98
- ARCT $18.44
- Resistance Level
- DHC $4.50
- ARCT $22.40
- Average True Range (ATR)
- DHC 0.15
- ARCT 2.00
- MACD
- DHC -0.06
- ARCT -0.13
- Stochastic Oscillator
- DHC 31.72
- ARCT 68.35
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.